Growth Metrics

Incyte (INCY) Current Deferred Revenue (2016)

Incyte filings provide 7 years of Current Deferred Revenue readings, the most recent being $2.9 million for Q3 2016.

  • For the quarter ending Q3 2016, Current Deferred Revenue fell 77.69% year-over-year to $2.9 million, compared with a TTM value of $2.9 million through Sep 2016, down 77.69%, and an annual FY2015 reading of $12.5 million, down 2.86% over the prior year.
  • Current Deferred Revenue hit $2.9 million in Q3 2016 for Incyte, down from $6.1 million in the prior quarter.
  • The five-year high for Current Deferred Revenue was $67.0 million in Q2 2012, with the low at $2.9 million in Q3 2016.
  • Median Current Deferred Revenue over the past 5 years was $12.9 million (2014), compared with a mean of $24.0 million.
  • The sharpest move saw Current Deferred Revenue tumbled 91.03% in 2012, then surged 775.17% in 2013.
  • Year by year, Current Deferred Revenue stood at $66.1 million in 2012, then plummeted by 80.49% to $12.9 million in 2013, then decreased by 0.08% to $12.9 million in 2014, then dropped by 2.86% to $12.5 million in 2015, then crashed by 77.08% to $2.9 million in 2016.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $2.9 million, $6.1 million, and $9.3 million for Q3 2016, Q2 2016, and Q1 2016 respectively.